nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—CYP3A7—Tamoxifen—pancreatic cancer	0.0549	0.0752	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0549	0.0752	CbGbCtD
Buspirone—CYP3A7—Irinotecan—pancreatic cancer	0.0422	0.0577	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0422	0.0577	CbGbCtD
Buspirone—CYP3A5—Tamoxifen—pancreatic cancer	0.0412	0.0564	CbGbCtD
Buspirone—CYP3A5—Erlotinib—pancreatic cancer	0.035	0.048	CbGbCtD
Buspirone—CYP3A5—Irinotecan—pancreatic cancer	0.0316	0.0433	CbGbCtD
Buspirone—CYP3A7—Docetaxel—pancreatic cancer	0.0309	0.0423	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0309	0.0423	CbGbCtD
Buspirone—CYP3A7—Sunitinib—pancreatic cancer	0.0308	0.0421	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0308	0.0421	CbGbCtD
Buspirone—ABCB1—Tamoxifen—pancreatic cancer	0.0268	0.0367	CbGbCtD
Buspirone—CYP2D6—Tamoxifen—pancreatic cancer	0.0253	0.0346	CbGbCtD
Buspirone—CYP3A5—Docetaxel—pancreatic cancer	0.0232	0.0317	CbGbCtD
Buspirone—ABCB1—Gemcitabine—pancreatic cancer	0.0231	0.0316	CbGbCtD
Buspirone—CYP3A5—Sunitinib—pancreatic cancer	0.0231	0.0316	CbGbCtD
Buspirone—ABCB1—Erlotinib—pancreatic cancer	0.0228	0.0312	CbGbCtD
Buspirone—CYP2D6—Erlotinib—pancreatic cancer	0.0215	0.0294	CbGbCtD
Buspirone—ABCB1—Irinotecan—pancreatic cancer	0.0206	0.0282	CbGbCtD
Buspirone—CYP3A4—Tamoxifen—pancreatic cancer	0.0161	0.022	CbGbCtD
Buspirone—ABCB1—Docetaxel—pancreatic cancer	0.0151	0.0207	CbGbCtD
Buspirone—ABCB1—Sunitinib—pancreatic cancer	0.015	0.0206	CbGbCtD
Buspirone—CYP3A4—Erlotinib—pancreatic cancer	0.0137	0.0187	CbGbCtD
Buspirone—CYP3A4—Irinotecan—pancreatic cancer	0.0123	0.0169	CbGbCtD
Buspirone—ABCB1—Doxorubicin—pancreatic cancer	0.0112	0.0154	CbGbCtD
Buspirone—CYP2D6—Doxorubicin—pancreatic cancer	0.0106	0.0145	CbGbCtD
Buspirone—CYP3A4—Docetaxel—pancreatic cancer	0.00904	0.0124	CbGbCtD
Buspirone—CYP3A4—Sunitinib—pancreatic cancer	0.009	0.0123	CbGbCtD
Buspirone—CYP3A4—Doxorubicin—pancreatic cancer	0.00674	0.00923	CbGbCtD
Buspirone—Fatigue—Irinotecan—pancreatic cancer	0.000228	0.00107	CcSEcCtD
Buspirone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000227	0.00107	CcSEcCtD
Buspirone—Alopecia—Docetaxel—pancreatic cancer	0.000227	0.00107	CcSEcCtD
Buspirone—Pruritus—Sunitinib—pancreatic cancer	0.000227	0.00107	CcSEcCtD
Buspirone—Pain—Irinotecan—pancreatic cancer	0.000226	0.00107	CcSEcCtD
Buspirone—Constipation—Irinotecan—pancreatic cancer	0.000226	0.00107	CcSEcCtD
Buspirone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000225	0.00106	CcSEcCtD
Buspirone—Somnolence—Fluorouracil—pancreatic cancer	0.000225	0.00106	CcSEcCtD
Buspirone—Face oedema—Doxorubicin—pancreatic cancer	0.000224	0.00106	CcSEcCtD
Buspirone—Erythema—Docetaxel—pancreatic cancer	0.000224	0.00106	CcSEcCtD
Buspirone—Decreased appetite—Gemcitabine—pancreatic cancer	0.000224	0.00106	CcSEcCtD
Buspirone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000223	0.00105	CcSEcCtD
Buspirone—Nausea—Tamoxifen—pancreatic cancer	0.000222	0.00105	CcSEcCtD
Buspirone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000222	0.00105	CcSEcCtD
Buspirone—Fatigue—Gemcitabine—pancreatic cancer	0.000222	0.00105	CcSEcCtD
Buspirone—Muscular weakness—Epirubicin—pancreatic cancer	0.000221	0.00104	CcSEcCtD
Buspirone—Constipation—Gemcitabine—pancreatic cancer	0.00022	0.00104	CcSEcCtD
Buspirone—Pain—Gemcitabine—pancreatic cancer	0.00022	0.00104	CcSEcCtD
Buspirone—Nausea—Erlotinib—pancreatic cancer	0.00022	0.00104	CcSEcCtD
Buspirone—Decreased appetite—Fluorouracil—pancreatic cancer	0.00022	0.00104	CcSEcCtD
Buspirone—Mood swings—Doxorubicin—pancreatic cancer	0.00022	0.00104	CcSEcCtD
Buspirone—Diarrhoea—Sunitinib—pancreatic cancer	0.000219	0.00104	CcSEcCtD
Buspirone—Dysgeusia—Docetaxel—pancreatic cancer	0.000219	0.00103	CcSEcCtD
Buspirone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000218	0.00103	CcSEcCtD
Buspirone—Ataxia—Doxorubicin—pancreatic cancer	0.000218	0.00103	CcSEcCtD
Buspirone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000218	0.00103	CcSEcCtD
Buspirone—Pain—Fluorouracil—pancreatic cancer	0.000216	0.00102	CcSEcCtD
Buspirone—Muscle spasms—Docetaxel—pancreatic cancer	0.000215	0.00102	CcSEcCtD
Buspirone—Eosinophilia—Epirubicin—pancreatic cancer	0.000214	0.00101	CcSEcCtD
Buspirone—Dry skin—Doxorubicin—pancreatic cancer	0.000212	0.001	CcSEcCtD
Buspirone—Dizziness—Sunitinib—pancreatic cancer	0.000212	0.001	CcSEcCtD
Buspirone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000212	0.001	CcSEcCtD
Buspirone—Body temperature increased—Irinotecan—pancreatic cancer	0.000209	0.000986	CcSEcCtD
Buspirone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000208	0.000984	CcSEcCtD
Buspirone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000204	0.000965	CcSEcCtD
Buspirone—Vomiting—Sunitinib—pancreatic cancer	0.000204	0.000962	CcSEcCtD
Buspirone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000203	0.00096	CcSEcCtD
Buspirone—Dysuria—Epirubicin—pancreatic cancer	0.000202	0.000956	CcSEcCtD
Buspirone—Rash—Sunitinib—pancreatic cancer	0.000202	0.000954	CcSEcCtD
Buspirone—Dermatitis—Sunitinib—pancreatic cancer	0.000202	0.000954	CcSEcCtD
Buspirone—Urticaria—Fluorouracil—pancreatic cancer	0.000201	0.000949	CcSEcCtD
Buspirone—Headache—Sunitinib—pancreatic cancer	0.000201	0.000948	CcSEcCtD
Buspirone—Syncope—Docetaxel—pancreatic cancer	0.000201	0.000947	CcSEcCtD
Buspirone—Leukopenia—Docetaxel—pancreatic cancer	0.0002	0.000945	CcSEcCtD
Buspirone—Pollakiuria—Epirubicin—pancreatic cancer	0.0002	0.000944	CcSEcCtD
Buspirone—Body temperature increased—Fluorouracil—pancreatic cancer	0.0002	0.000944	CcSEcCtD
Buspirone—Eosinophilia—Doxorubicin—pancreatic cancer	0.000198	0.000937	CcSEcCtD
Buspirone—Palpitations—Docetaxel—pancreatic cancer	0.000198	0.000933	CcSEcCtD
Buspirone—Weight increased—Epirubicin—pancreatic cancer	0.000197	0.00093	CcSEcCtD
Buspirone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000197	0.000928	CcSEcCtD
Buspirone—Weight decreased—Epirubicin—pancreatic cancer	0.000196	0.000925	CcSEcCtD
Buspirone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000194	0.000919	CcSEcCtD
Buspirone—Convulsion—Docetaxel—pancreatic cancer	0.000194	0.000915	CcSEcCtD
Buspirone—Hypertension—Docetaxel—pancreatic cancer	0.000193	0.000912	CcSEcCtD
Buspirone—Drowsiness—Epirubicin—pancreatic cancer	0.000193	0.000912	CcSEcCtD
Buspirone—Chest pain—Docetaxel—pancreatic cancer	0.00019	0.000899	CcSEcCtD
Buspirone—Myalgia—Docetaxel—pancreatic cancer	0.00019	0.000899	CcSEcCtD
Buspirone—Arthralgia—Docetaxel—pancreatic cancer	0.00019	0.000899	CcSEcCtD
Buspirone—Nausea—Sunitinib—pancreatic cancer	0.00019	0.000899	CcSEcCtD
Buspirone—Asthenia—Irinotecan—pancreatic cancer	0.000189	0.000895	CcSEcCtD
Buspirone—Conjunctivitis—Epirubicin—pancreatic cancer	0.000188	0.000886	CcSEcCtD
Buspirone—Dysuria—Doxorubicin—pancreatic cancer	0.000187	0.000885	CcSEcCtD
Buspirone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000186	0.00088	CcSEcCtD
Buspirone—Dry mouth—Docetaxel—pancreatic cancer	0.000186	0.000879	CcSEcCtD
Buspirone—Sweating—Epirubicin—pancreatic cancer	0.000185	0.000874	CcSEcCtD
Buspirone—Pollakiuria—Doxorubicin—pancreatic cancer	0.000185	0.000874	CcSEcCtD
Buspirone—Asthenia—Gemcitabine—pancreatic cancer	0.000184	0.000871	CcSEcCtD
Buspirone—Confusional state—Docetaxel—pancreatic cancer	0.000184	0.000869	CcSEcCtD
Buspirone—Oedema—Docetaxel—pancreatic cancer	0.000182	0.000862	CcSEcCtD
Buspirone—Weight increased—Doxorubicin—pancreatic cancer	0.000182	0.000861	CcSEcCtD
Buspirone—Epistaxis—Epirubicin—pancreatic cancer	0.000182	0.00086	CcSEcCtD
Buspirone—Pruritus—Gemcitabine—pancreatic cancer	0.000182	0.000859	CcSEcCtD
Buspirone—Weight decreased—Doxorubicin—pancreatic cancer	0.000181	0.000856	CcSEcCtD
Buspirone—Diarrhoea—Irinotecan—pancreatic cancer	0.000181	0.000853	CcSEcCtD
Buspirone—Shock—Docetaxel—pancreatic cancer	0.00018	0.000848	CcSEcCtD
Buspirone—Pruritus—Fluorouracil—pancreatic cancer	0.000179	0.000845	CcSEcCtD
Buspirone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000179	0.000844	CcSEcCtD
Buspirone—Drowsiness—Doxorubicin—pancreatic cancer	0.000179	0.000843	CcSEcCtD
Buspirone—Tachycardia—Docetaxel—pancreatic cancer	0.000178	0.000841	CcSEcCtD
Buspirone—Bradycardia—Epirubicin—pancreatic cancer	0.000176	0.000833	CcSEcCtD
Buspirone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000176	0.000831	CcSEcCtD
Buspirone—Dizziness—Irinotecan—pancreatic cancer	0.000175	0.000825	CcSEcCtD
Buspirone—Haemoglobin—Epirubicin—pancreatic cancer	0.000174	0.000822	CcSEcCtD
Buspirone—Anorexia—Docetaxel—pancreatic cancer	0.000174	0.000822	CcSEcCtD
Buspirone—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000174	0.00082	CcSEcCtD
Buspirone—Haemorrhage—Epirubicin—pancreatic cancer	0.000173	0.000818	CcSEcCtD
Buspirone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000173	0.000817	CcSEcCtD
Buspirone—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000172	0.000814	CcSEcCtD
Buspirone—Sweating—Doxorubicin—pancreatic cancer	0.000171	0.000809	CcSEcCtD
Buspirone—Hypotension—Docetaxel—pancreatic cancer	0.000171	0.000805	CcSEcCtD
Buspirone—Epistaxis—Doxorubicin—pancreatic cancer	0.000168	0.000796	CcSEcCtD
Buspirone—Vomiting—Irinotecan—pancreatic cancer	0.000168	0.000793	CcSEcCtD
Buspirone—Dizziness—Fluorouracil—pancreatic cancer	0.000167	0.00079	CcSEcCtD
Buspirone—Rash—Irinotecan—pancreatic cancer	0.000166	0.000786	CcSEcCtD
Buspirone—Dermatitis—Irinotecan—pancreatic cancer	0.000166	0.000785	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000166	0.000785	CcSEcCtD
Buspirone—Headache—Irinotecan—pancreatic cancer	0.000165	0.000781	CcSEcCtD
Buspirone—Insomnia—Docetaxel—pancreatic cancer	0.000165	0.00078	CcSEcCtD
Buspirone—Paraesthesia—Docetaxel—pancreatic cancer	0.000164	0.000774	CcSEcCtD
Buspirone—Vomiting—Gemcitabine—pancreatic cancer	0.000163	0.000772	CcSEcCtD
Buspirone—Bradycardia—Doxorubicin—pancreatic cancer	0.000163	0.000771	CcSEcCtD
Buspirone—Dyspnoea—Docetaxel—pancreatic cancer	0.000163	0.000768	CcSEcCtD
Buspirone—Somnolence—Docetaxel—pancreatic cancer	0.000162	0.000766	CcSEcCtD
Buspirone—Rash—Gemcitabine—pancreatic cancer	0.000162	0.000766	CcSEcCtD
Buspirone—Dermatitis—Gemcitabine—pancreatic cancer	0.000162	0.000765	CcSEcCtD
Buspirone—Tinnitus—Epirubicin—pancreatic cancer	0.000162	0.000763	CcSEcCtD
Buspirone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000161	0.000761	CcSEcCtD
Buspirone—Headache—Gemcitabine—pancreatic cancer	0.000161	0.000761	CcSEcCtD
Buspirone—Flushing—Epirubicin—pancreatic cancer	0.000161	0.000759	CcSEcCtD
Buspirone—Vomiting—Fluorouracil—pancreatic cancer	0.000161	0.000759	CcSEcCtD
Buspirone—Dyspepsia—Docetaxel—pancreatic cancer	0.000161	0.000759	CcSEcCtD
Buspirone—Haemorrhage—Doxorubicin—pancreatic cancer	0.00016	0.000757	CcSEcCtD
Buspirone—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000159	0.000753	CcSEcCtD
Buspirone—Rash—Fluorouracil—pancreatic cancer	0.000159	0.000753	CcSEcCtD
Buspirone—Dermatitis—Fluorouracil—pancreatic cancer	0.000159	0.000752	CcSEcCtD
Buspirone—Decreased appetite—Docetaxel—pancreatic cancer	0.000159	0.000749	CcSEcCtD
Buspirone—Headache—Fluorouracil—pancreatic cancer	0.000158	0.000748	CcSEcCtD
Buspirone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000158	0.000744	CcSEcCtD
Buspirone—Fatigue—Docetaxel—pancreatic cancer	0.000157	0.000743	CcSEcCtD
Buspirone—Nausea—Irinotecan—pancreatic cancer	0.000157	0.000741	CcSEcCtD
Buspirone—Constipation—Docetaxel—pancreatic cancer	0.000156	0.000737	CcSEcCtD
Buspirone—Pain—Docetaxel—pancreatic cancer	0.000156	0.000737	CcSEcCtD
Buspirone—Chills—Epirubicin—pancreatic cancer	0.000155	0.000734	CcSEcCtD
Buspirone—Alopecia—Epirubicin—pancreatic cancer	0.000153	0.000723	CcSEcCtD
Buspirone—Nausea—Gemcitabine—pancreatic cancer	0.000153	0.000721	CcSEcCtD
Buspirone—Erythema—Epirubicin—pancreatic cancer	0.000151	0.000712	CcSEcCtD
Buspirone—Feeling abnormal—Docetaxel—pancreatic cancer	0.00015	0.00071	CcSEcCtD
Buspirone—Nausea—Fluorouracil—pancreatic cancer	0.00015	0.000709	CcSEcCtD
Buspirone—Tinnitus—Doxorubicin—pancreatic cancer	0.000149	0.000706	CcSEcCtD
Buspirone—Flushing—Doxorubicin—pancreatic cancer	0.000149	0.000703	CcSEcCtD
Buspirone—Flatulence—Epirubicin—pancreatic cancer	0.000149	0.000702	CcSEcCtD
Buspirone—Tension—Epirubicin—pancreatic cancer	0.000148	0.000699	CcSEcCtD
Buspirone—Dysgeusia—Epirubicin—pancreatic cancer	0.000148	0.000698	CcSEcCtD
Buspirone—Nervousness—Epirubicin—pancreatic cancer	0.000146	0.000692	CcSEcCtD
Buspirone—Muscle spasms—Epirubicin—pancreatic cancer	0.000145	0.000685	CcSEcCtD
Buspirone—Body temperature increased—Docetaxel—pancreatic cancer	0.000144	0.000681	CcSEcCtD
Buspirone—Chills—Doxorubicin—pancreatic cancer	0.000144	0.000679	CcSEcCtD
Buspirone—Vision blurred—Epirubicin—pancreatic cancer	0.000142	0.000671	CcSEcCtD
Buspirone—Alopecia—Doxorubicin—pancreatic cancer	0.000142	0.000669	CcSEcCtD
Buspirone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00014	0.000661	CcSEcCtD
Buspirone—Erythema—Doxorubicin—pancreatic cancer	0.00014	0.000659	CcSEcCtD
Buspirone—Agitation—Epirubicin—pancreatic cancer	0.000139	0.000655	CcSEcCtD
Buspirone—Flatulence—Doxorubicin—pancreatic cancer	0.000138	0.000649	CcSEcCtD
Buspirone—Tension—Doxorubicin—pancreatic cancer	0.000137	0.000647	CcSEcCtD
Buspirone—Dysgeusia—Doxorubicin—pancreatic cancer	0.000137	0.000645	CcSEcCtD
Buspirone—Malaise—Epirubicin—pancreatic cancer	0.000136	0.000642	CcSEcCtD
Buspirone—Nervousness—Doxorubicin—pancreatic cancer	0.000136	0.00064	CcSEcCtD
Buspirone—Vertigo—Epirubicin—pancreatic cancer	0.000135	0.00064	CcSEcCtD
Buspirone—Syncope—Epirubicin—pancreatic cancer	0.000135	0.000639	CcSEcCtD
Buspirone—Leukopenia—Epirubicin—pancreatic cancer	0.000135	0.000638	CcSEcCtD
Buspirone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000134	0.000635	CcSEcCtD
Buspirone—Muscle spasms—Doxorubicin—pancreatic cancer	0.000134	0.000634	CcSEcCtD
Buspirone—Palpitations—Epirubicin—pancreatic cancer	0.000133	0.000629	CcSEcCtD
Buspirone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000133	0.000626	CcSEcCtD
Buspirone—Vision blurred—Doxorubicin—pancreatic cancer	0.000132	0.000621	CcSEcCtD
Buspirone—Asthenia—Docetaxel—pancreatic cancer	0.000131	0.000618	CcSEcCtD
Buspirone—Convulsion—Epirubicin—pancreatic cancer	0.000131	0.000617	CcSEcCtD
Buspirone—Hypertension—Epirubicin—pancreatic cancer	0.00013	0.000615	CcSEcCtD
Buspirone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000129	0.000612	CcSEcCtD
Buspirone—Pruritus—Docetaxel—pancreatic cancer	0.000129	0.00061	CcSEcCtD
Buspirone—Myalgia—Epirubicin—pancreatic cancer	0.000128	0.000606	CcSEcCtD
Buspirone—Chest pain—Epirubicin—pancreatic cancer	0.000128	0.000606	CcSEcCtD
Buspirone—Arthralgia—Epirubicin—pancreatic cancer	0.000128	0.000606	CcSEcCtD
Buspirone—Agitation—Doxorubicin—pancreatic cancer	0.000128	0.000606	CcSEcCtD
Buspirone—Discomfort—Epirubicin—pancreatic cancer	0.000127	0.000599	CcSEcCtD
Buspirone—Malaise—Doxorubicin—pancreatic cancer	0.000126	0.000594	CcSEcCtD
Buspirone—Dry mouth—Epirubicin—pancreatic cancer	0.000126	0.000593	CcSEcCtD
Buspirone—Vertigo—Doxorubicin—pancreatic cancer	0.000125	0.000592	CcSEcCtD
Buspirone—Syncope—Doxorubicin—pancreatic cancer	0.000125	0.000591	CcSEcCtD
Buspirone—Leukopenia—Doxorubicin—pancreatic cancer	0.000125	0.00059	CcSEcCtD
Buspirone—Diarrhoea—Docetaxel—pancreatic cancer	0.000125	0.00059	CcSEcCtD
Buspirone—Confusional state—Epirubicin—pancreatic cancer	0.000124	0.000586	CcSEcCtD
Buspirone—Palpitations—Doxorubicin—pancreatic cancer	0.000123	0.000582	CcSEcCtD
Buspirone—Oedema—Epirubicin—pancreatic cancer	0.000123	0.000581	CcSEcCtD
Buspirone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000123	0.000579	CcSEcCtD
Buspirone—Shock—Epirubicin—pancreatic cancer	0.000121	0.000572	CcSEcCtD
Buspirone—Convulsion—Doxorubicin—pancreatic cancer	0.000121	0.000571	CcSEcCtD
Buspirone—Dizziness—Docetaxel—pancreatic cancer	0.000121	0.00057	CcSEcCtD
Buspirone—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000121	0.000569	CcSEcCtD
Buspirone—Hypertension—Doxorubicin—pancreatic cancer	0.00012	0.000569	CcSEcCtD
Buspirone—Tachycardia—Epirubicin—pancreatic cancer	0.00012	0.000567	CcSEcCtD
Buspirone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000119	0.000562	CcSEcCtD
Buspirone—Chest pain—Doxorubicin—pancreatic cancer	0.000119	0.000561	CcSEcCtD
Buspirone—Arthralgia—Doxorubicin—pancreatic cancer	0.000119	0.000561	CcSEcCtD
Buspirone—Myalgia—Doxorubicin—pancreatic cancer	0.000119	0.000561	CcSEcCtD
Buspirone—Discomfort—Doxorubicin—pancreatic cancer	0.000117	0.000554	CcSEcCtD
Buspirone—Anorexia—Epirubicin—pancreatic cancer	0.000117	0.000554	CcSEcCtD
Buspirone—Dry mouth—Doxorubicin—pancreatic cancer	0.000116	0.000549	CcSEcCtD
Buspirone—Vomiting—Docetaxel—pancreatic cancer	0.000116	0.000548	CcSEcCtD
Buspirone—Rash—Docetaxel—pancreatic cancer	0.000115	0.000543	CcSEcCtD
Buspirone—Hypotension—Epirubicin—pancreatic cancer	0.000115	0.000543	CcSEcCtD
Buspirone—Dermatitis—Docetaxel—pancreatic cancer	0.000115	0.000543	CcSEcCtD
Buspirone—Confusional state—Doxorubicin—pancreatic cancer	0.000115	0.000542	CcSEcCtD
Buspirone—Headache—Docetaxel—pancreatic cancer	0.000114	0.00054	CcSEcCtD
Buspirone—Oedema—Doxorubicin—pancreatic cancer	0.000114	0.000538	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000112	0.00053	CcSEcCtD
Buspirone—Shock—Doxorubicin—pancreatic cancer	0.000112	0.000529	CcSEcCtD
Buspirone—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000112	0.000527	CcSEcCtD
Buspirone—Insomnia—Epirubicin—pancreatic cancer	0.000111	0.000526	CcSEcCtD
Buspirone—Tachycardia—Doxorubicin—pancreatic cancer	0.000111	0.000525	CcSEcCtD
Buspirone—Paraesthesia—Epirubicin—pancreatic cancer	0.000111	0.000522	CcSEcCtD
Buspirone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00011	0.00052	CcSEcCtD
Buspirone—Dyspnoea—Epirubicin—pancreatic cancer	0.00011	0.000518	CcSEcCtD
Buspirone—Somnolence—Epirubicin—pancreatic cancer	0.000109	0.000517	CcSEcCtD
Buspirone—Anorexia—Doxorubicin—pancreatic cancer	0.000109	0.000513	CcSEcCtD
Buspirone—Nausea—Docetaxel—pancreatic cancer	0.000108	0.000512	CcSEcCtD
Buspirone—Dyspepsia—Epirubicin—pancreatic cancer	0.000108	0.000512	CcSEcCtD
Buspirone—Decreased appetite—Epirubicin—pancreatic cancer	0.000107	0.000505	CcSEcCtD
Buspirone—Hypotension—Doxorubicin—pancreatic cancer	0.000106	0.000503	CcSEcCtD
Buspirone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000106	0.000502	CcSEcCtD
Buspirone—Fatigue—Epirubicin—pancreatic cancer	0.000106	0.000501	CcSEcCtD
Buspirone—Pain—Epirubicin—pancreatic cancer	0.000105	0.000497	CcSEcCtD
Buspirone—Constipation—Epirubicin—pancreatic cancer	0.000105	0.000497	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000104	0.00049	CcSEcCtD
Buspirone—Insomnia—Doxorubicin—pancreatic cancer	0.000103	0.000487	CcSEcCtD
Buspirone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000102	0.000483	CcSEcCtD
Buspirone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000102	0.00048	CcSEcCtD
Buspirone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000101	0.000479	CcSEcCtD
Buspirone—Somnolence—Doxorubicin—pancreatic cancer	0.000101	0.000478	CcSEcCtD
Buspirone—Dyspepsia—Doxorubicin—pancreatic cancer	0.0001	0.000473	CcSEcCtD
Buspirone—Decreased appetite—Doxorubicin—pancreatic cancer	9.9e-05	0.000468	CcSEcCtD
Buspirone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.83e-05	0.000464	CcSEcCtD
Buspirone—Fatigue—Doxorubicin—pancreatic cancer	9.82e-05	0.000464	CcSEcCtD
Buspirone—Urticaria—Epirubicin—pancreatic cancer	9.78e-05	0.000462	CcSEcCtD
Buspirone—Constipation—Doxorubicin—pancreatic cancer	9.74e-05	0.00046	CcSEcCtD
Buspirone—Pain—Doxorubicin—pancreatic cancer	9.74e-05	0.00046	CcSEcCtD
Buspirone—Body temperature increased—Epirubicin—pancreatic cancer	9.73e-05	0.00046	CcSEcCtD
Buspirone—Feeling abnormal—Doxorubicin—pancreatic cancer	9.38e-05	0.000443	CcSEcCtD
Buspirone—Hypersensitivity—Epirubicin—pancreatic cancer	9.07e-05	0.000428	CcSEcCtD
Buspirone—Urticaria—Doxorubicin—pancreatic cancer	9.05e-05	0.000427	CcSEcCtD
Buspirone—Body temperature increased—Doxorubicin—pancreatic cancer	9e-05	0.000425	CcSEcCtD
Buspirone—Asthenia—Epirubicin—pancreatic cancer	8.83e-05	0.000417	CcSEcCtD
Buspirone—Pruritus—Epirubicin—pancreatic cancer	8.71e-05	0.000411	CcSEcCtD
Buspirone—Diarrhoea—Epirubicin—pancreatic cancer	8.42e-05	0.000398	CcSEcCtD
Buspirone—Hypersensitivity—Doxorubicin—pancreatic cancer	8.39e-05	0.000396	CcSEcCtD
Buspirone—Asthenia—Doxorubicin—pancreatic cancer	8.17e-05	0.000386	CcSEcCtD
Buspirone—Dizziness—Epirubicin—pancreatic cancer	8.14e-05	0.000384	CcSEcCtD
Buspirone—Pruritus—Doxorubicin—pancreatic cancer	8.06e-05	0.000381	CcSEcCtD
Buspirone—Vomiting—Epirubicin—pancreatic cancer	7.83e-05	0.00037	CcSEcCtD
Buspirone—Diarrhoea—Doxorubicin—pancreatic cancer	7.79e-05	0.000368	CcSEcCtD
Buspirone—Rash—Epirubicin—pancreatic cancer	7.76e-05	0.000367	CcSEcCtD
Buspirone—Dermatitis—Epirubicin—pancreatic cancer	7.75e-05	0.000366	CcSEcCtD
Buspirone—Headache—Epirubicin—pancreatic cancer	7.71e-05	0.000364	CcSEcCtD
Buspirone—Dizziness—Doxorubicin—pancreatic cancer	7.53e-05	0.000356	CcSEcCtD
Buspirone—Nausea—Epirubicin—pancreatic cancer	7.31e-05	0.000345	CcSEcCtD
Buspirone—Vomiting—Doxorubicin—pancreatic cancer	7.24e-05	0.000342	CcSEcCtD
Buspirone—Rash—Doxorubicin—pancreatic cancer	7.18e-05	0.000339	CcSEcCtD
Buspirone—Dermatitis—Doxorubicin—pancreatic cancer	7.17e-05	0.000339	CcSEcCtD
Buspirone—Headache—Doxorubicin—pancreatic cancer	7.13e-05	0.000337	CcSEcCtD
Buspirone—Nausea—Doxorubicin—pancreatic cancer	6.76e-05	0.00032	CcSEcCtD
Buspirone—DRD3—Signaling Pathways—APOE—pancreatic cancer	1.27e-05	0.000219	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NOTCH1—pancreatic cancer	1.26e-05	0.000218	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.25e-05	0.000216	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	1.24e-05	0.000215	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KDR—pancreatic cancer	1.24e-05	0.000215	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.23e-05	0.000213	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CG—pancreatic cancer	1.23e-05	0.000213	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—NRAS—pancreatic cancer	1.23e-05	0.000213	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGF—pancreatic cancer	1.22e-05	0.00021	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	1.22e-05	0.00021	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.2e-05	0.000208	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.2e-05	0.000208	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SMAD4—pancreatic cancer	1.2e-05	0.000207	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.19e-05	0.000206	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HES1—pancreatic cancer	1.19e-05	0.000205	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TERT—pancreatic cancer	1.18e-05	0.000205	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.18e-05	0.000205	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NFKBIA—pancreatic cancer	1.18e-05	0.000205	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.17e-05	0.000203	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NOTCH1—pancreatic cancer	1.17e-05	0.000203	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HES1—pancreatic cancer	1.17e-05	0.000202	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.15e-05	0.000199	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CG—pancreatic cancer	1.15e-05	0.000198	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—NRAS—pancreatic cancer	1.15e-05	0.000198	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CD44—pancreatic cancer	1.14e-05	0.000197	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.14e-05	0.000197	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	1.13e-05	0.000196	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGF—pancreatic cancer	1.13e-05	0.000196	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	1.13e-05	0.000195	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—EGFR—pancreatic cancer	1.12e-05	0.000194	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.12e-05	0.000193	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—APOE—pancreatic cancer	1.11e-05	0.000191	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GCG—pancreatic cancer	1.09e-05	0.000189	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	1.09e-05	0.000189	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KDR—pancreatic cancer	1.08e-05	0.000187	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CD—pancreatic cancer	1.08e-05	0.000187	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.07e-05	0.000186	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CD44—pancreatic cancer	1.07e-05	0.000186	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.07e-05	0.000185	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—KRAS—pancreatic cancer	1.06e-05	0.000183	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	1.05e-05	0.000181	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—EGFR—pancreatic cancer	1.04e-05	0.00018	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TERT—pancreatic cancer	1.04e-05	0.00018	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.03e-05	0.000178	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GCG—pancreatic cancer	1.03e-05	0.000178	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—STK11—pancreatic cancer	1.03e-05	0.000178	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TERT—pancreatic cancer	1.02e-05	0.000177	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.02e-05	0.000177	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CD—pancreatic cancer	1.01e-05	0.000174	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	9.98e-06	0.000173	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	9.98e-06	0.000173	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.97e-06	0.000172	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	9.95e-06	0.000172	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TSC2—pancreatic cancer	9.92e-06	0.000172	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGF—pancreatic cancer	9.86e-06	0.000171	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—KRAS—pancreatic cancer	9.86e-06	0.00017	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HIF1A—pancreatic cancer	9.79e-06	0.000169	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TSC2—pancreatic cancer	9.76e-06	0.000169	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—PIK3CA—pancreatic cancer	9.73e-06	0.000168	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.71e-06	0.000168	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—APOE—pancreatic cancer	9.71e-06	0.000168	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—STK11—pancreatic cancer	9.68e-06	0.000167	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.56e-06	0.000165	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—APOE—pancreatic cancer	9.55e-06	0.000165	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—APOE—pancreatic cancer	9.52e-06	0.000165	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KDR—pancreatic cancer	9.51e-06	0.000165	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CB—pancreatic cancer	9.43e-06	0.000163	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KDR—pancreatic cancer	9.36e-06	0.000162	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	9.11e-06	0.000158	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	9.09e-06	0.000157	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.07e-06	0.000157	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CXCL8—pancreatic cancer	9.06e-06	0.000157	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—PIK3CA—pancreatic cancer	9.05e-06	0.000157	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	9.05e-06	0.000156	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTGS2—pancreatic cancer	9.03e-06	0.000156	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—HRAS—pancreatic cancer	9e-06	0.000156	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	8.96e-06	0.000155	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NFKBIA—pancreatic cancer	8.9e-06	0.000154	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—TYMS—pancreatic cancer	8.84e-06	0.000153	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOTCH1—pancreatic cancer	8.82e-06	0.000152	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CB—pancreatic cancer	8.77e-06	0.000152	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	8.77e-06	0.000152	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	8.76e-06	0.000152	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	8.76e-06	0.000152	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—AKT1—pancreatic cancer	8.75e-06	0.000151	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.69e-06	0.00015	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CASP3—pancreatic cancer	8.67e-06	0.00015	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGF—pancreatic cancer	8.66e-06	0.00015	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CG—pancreatic cancer	8.62e-06	0.000149	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—NRAS—pancreatic cancer	8.62e-06	0.000149	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	8.6e-06	0.000149	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	8.59e-06	0.000149	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGF—pancreatic cancer	8.52e-06	0.000147	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCND1—pancreatic cancer	8.44e-06	0.000146	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CXCL8—pancreatic cancer	8.43e-06	0.000146	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HRAS—pancreatic cancer	8.38e-06	0.000145	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CTNNB1—pancreatic cancer	8.36e-06	0.000145	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TYMS—pancreatic cancer	8.33e-06	0.000144	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PPARG—pancreatic cancer	8.3e-06	0.000144	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MMP9—pancreatic cancer	8.2e-06	0.000142	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PTEN—pancreatic cancer	8.15e-06	0.000141	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—AKT1—pancreatic cancer	8.15e-06	0.000141	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CASP3—pancreatic cancer	8.07e-06	0.00014	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	7.98e-06	0.000138	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—AKT1—pancreatic cancer	7.95e-06	0.000137	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.89e-06	0.000136	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTEN—pancreatic cancer	7.87e-06	0.000136	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCND1—pancreatic cancer	7.86e-06	0.000136	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	7.85e-06	0.000136	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CTNNB1—pancreatic cancer	7.78e-06	0.000135	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	7.7e-06	0.000133	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	7.65e-06	0.000132	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.63e-06	0.000132	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MMP9—pancreatic cancer	7.63e-06	0.000132	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PTEN—pancreatic cancer	7.58e-06	0.000131	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	7.58e-06	0.000131	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	7.56e-06	0.000131	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SRC—pancreatic cancer	7.56e-06	0.000131	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	7.54e-06	0.00013	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.51e-06	0.00013	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	7.42e-06	0.000128	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—AKT1—pancreatic cancer	7.4e-06	0.000128	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—VEGFA—pancreatic cancer	7.36e-06	0.000127	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	7.35e-06	0.000127	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	7.3e-06	0.000126	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	7.29e-06	0.000126	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	7.27e-06	0.000126	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—APOE—pancreatic cancer	7.19e-06	0.000124	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	7.1e-06	0.000123	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	7.03e-06	0.000122	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SRC—pancreatic cancer	7.03e-06	0.000122	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CD44—pancreatic cancer	7.02e-06	0.000121	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	6.93e-06	0.00012	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	6.85e-06	0.000118	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	6.85e-06	0.000118	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.82e-06	0.000118	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STAT3—pancreatic cancer	6.78e-06	0.000117	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	6.78e-06	0.000117	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—APOE—pancreatic cancer	6.77e-06	0.000117	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MYC—pancreatic cancer	6.77e-06	0.000117	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NRAS—pancreatic cancer	6.76e-06	0.000117	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	6.75e-06	0.000117	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GCG—pancreatic cancer	6.73e-06	0.000116	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	6.71e-06	0.000116	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	6.65e-06	0.000115	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	6.62e-06	0.000115	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	6.61e-06	0.000114	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	6.61e-06	0.000114	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	6.59e-06	0.000114	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—pancreatic cancer	6.53e-06	0.000113	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.49e-06	0.000112	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	6.45e-06	0.000112	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	6.45e-06	0.000112	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	6.41e-06	0.000111	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	6.35e-06	0.00011	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—STK11—pancreatic cancer	6.33e-06	0.000109	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	6.31e-06	0.000109	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MYC—pancreatic cancer	6.3e-06	0.000109	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	6.29e-06	0.000109	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PPARG—pancreatic cancer	6.26e-06	0.000108	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	6.26e-06	0.000108	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	6.23e-06	0.000108	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CASP3—pancreatic cancer	6.18e-06	0.000107	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—pancreatic cancer	6.16e-06	0.000107	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	6.13e-06	0.000106	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SRC—pancreatic cancer	6.13e-06	0.000106	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	6.11e-06	0.000106	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	6.08e-06	0.000105	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCND1—pancreatic cancer	6.01e-06	0.000104	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	5.97e-06	0.000103	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	5.95e-06	0.000103	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	5.91e-06	0.000102	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	5.91e-06	0.000102	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.9e-06	0.000102	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	5.9e-06	0.000102	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	5.86e-06	0.000101	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MMP9—pancreatic cancer	5.84e-06	0.000101	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KRAS—pancreatic cancer	5.82e-06	0.000101	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTEN—pancreatic cancer	5.8e-06	0.0001	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	5.75e-06	9.94e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	5.74e-06	9.93e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	5.71e-06	9.87e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.7e-06	9.86e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTEN—pancreatic cancer	5.69e-06	9.84e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	5.66e-06	9.79e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	5.57e-06	9.63e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—pancreatic cancer	5.56e-06	9.62e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	5.55e-06	9.61e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MYC—pancreatic cancer	5.49e-06	9.5e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	5.48e-06	9.48e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.44e-06	9.42e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SRC—pancreatic cancer	5.38e-06	9.31e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.37e-06	9.29e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	5.37e-06	9.29e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	5.35e-06	9.25e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	5.32e-06	9.2e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SRC—pancreatic cancer	5.29e-06	9.16e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	5.24e-06	9.06e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STAT3—pancreatic cancer	5.19e-06	8.97e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NRAS—pancreatic cancer	5.18e-06	8.95e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—pancreatic cancer	5.17e-06	8.95e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	5.16e-06	8.92e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	5.11e-06	8.83e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	5.09e-06	8.81e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	5.07e-06	8.78e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.97e-06	8.6e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HRAS—pancreatic cancer	4.95e-06	8.56e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.92e-06	8.52e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MYC—pancreatic cancer	4.82e-06	8.34e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	4.81e-06	8.32e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MYC—pancreatic cancer	4.74e-06	8.21e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	4.73e-06	8.19e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—pancreatic cancer	4.72e-06	8.16e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	4.7e-06	8.12e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.68e-06	8.1e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.66e-06	8.06e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.64e-06	8.03e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	4.64e-06	8.03e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AKT1—pancreatic cancer	4.54e-06	7.85e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—pancreatic cancer	4.51e-06	7.8e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KRAS—pancreatic cancer	4.45e-06	7.71e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOE—pancreatic cancer	4.43e-06	7.66e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	4.38e-06	7.58e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—AKT1—pancreatic cancer	4.37e-06	7.56e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	4.31e-06	7.46e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTEN—pancreatic cancer	4.29e-06	7.43e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	4.09e-06	7.08e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.05e-06	7e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.03e-06	6.97e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	4.02e-06	6.95e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4e-06	6.91e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—pancreatic cancer	3.96e-06	6.85e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—pancreatic cancer	3.9e-06	6.74e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.86e-06	6.67e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	3.81e-06	6.59e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HRAS—pancreatic cancer	3.79e-06	6.55e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	3.73e-06	6.44e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.51e-06	6.08e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AKT1—pancreatic cancer	3.34e-06	5.78e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	3.29e-06	5.69e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AKT1—pancreatic cancer	3.28e-06	5.67e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.06e-06	5.3e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.03e-06	5.25e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.03e-06	5.24e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.86e-06	4.94e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.65e-06	4.58e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AKT1—pancreatic cancer	2.48e-06	4.28e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.33e-06	4.03e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.87e-06	3.23e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.52e-06	2.64e-05	CbGpPWpGaD
